表紙:水和物阻害剤の世界市場:規模、シェア、動向、予測(2022年~2028年)
市場調査レポート
商品コード
1084481

水和物阻害剤の世界市場:規模、シェア、動向、予測(2022年~2028年)

Hydrate Inhibitor Market - Size, Share, trends, and Forecast, 2022 - 2028

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 125 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
水和物阻害剤の世界市場:規模、シェア、動向、予測(2022年~2028年)
出版日: 2022年05月16日
発行: Coherent Market Insights
ページ情報: 英文 125 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の水和物阻害剤の市場規模は、天然ガスと石油の需要増加などによって促進されています。

当レポートでは、世界の水和物阻害剤市場を調査しており、市場の概要、市場規模や予測、動向、成長要因、抑制要因、阻害剤タイプ・地域別の分析、および競合情勢などを提供しています。

目次

第1章 調査目的・前提条件

  • 調査目的
  • 仮定
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場内訳:阻害剤タイプ別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、および動向分析

  • 市場力学
    • 促進要因
    • 供給側の成長要因
    • 需要側の成長要因
    • 経済的推進力
    • 抑制要因
    • 市場機会
    • 規制シナリオ
    • 業界動向
    • 合併と買収
    • 新製品の承認/発売
    • プロモーションおよびマーケティングイニシアチブ
  • コストティアダウン分析

第4章 世界の水和物阻害剤市場:阻害剤タイプ別(2017年~2028年)

  • イントロダクション
  • 熱力学的阻害剤
  • 低用量水和物阻害剤(LDHI)
  • ハイブリッド

第5章 世界の水和物阻害剤市場:地域別(2017年~2028年)

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東
  • アフリカ

第6章 競合情勢

  • ヒートマップ分析
  • 市場シェア分析(3x3マトリックス)
  • 企業プロファイル
    • Halliburton
    • Ashland Global Specialty Chemicals Inc.
    • Ecolab Inc.
    • Baker Hughes Inc.
    • Innospec Inc.
    • JSC Gazprom Neftekhim Salavat
    • BASF SE
    • Evonik Industries Ag
    • Clariant AG
    • GasHydrate LLC
    • Schlumberger Limited
  • アナリストの見解

第7章 セクション

目次
Product Code: CMI555

Hydrate inhibitors are used to prevent or reduce gas hydrate formation. Gas hydrates are formed in offshore production systems under low temperature and high pressure conditions. These hydrates block pipelines, drill strings, BOP’s, by forming plugs, and cause flow assurance issues. Hydrate inhibitors are used where mechanical methods such as insulated flow line and active heating are not feasible options. However, political instability and low price of oil is a major factor negatively affecting growth of the global hydrate inhibitors market.

Market Dynamics

Increasing demand for natural gas and oil is expected to boost the global hydrate inhibitors market growth. Global demand for energy is increasing rapidly. Moreover, world natural gas consumption is expected to increase by 43% from 2015 to 2040 according to the International Energy Outlook 2021, as natural gas continues to be the fuel for electric power generation and for application in industrial sectors. Electric power and industrial sector uses around 75% of the natural gas of the projected increase in total consumption between 2015 and 2040.

By region, North America held a major market share of 58% in 2021. Middle East and Europe held significant market share in the global hydrate inhibitors market.

Europe is a lucrative market for hydrate inhibitors with significant demand due to high offshore oil production from the region in 2021 and it is expected to increase during forecast period. For instance, according to the EU, 567 million barrels of offshore oil had been produced in the U.K. in 2012. Furthermore, 95 million barrels of offshore oil and 105 million barrels of offshore gas production was recorded in Norway in 2012, according to the EU.

Key features of the study:

This report provides in-depth analysis of hydrate inhibitors market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global hydrate inhibitors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Key companies covered as a part of this study includes Halliburton, Ashland Global Specialty Chemicals Inc., Ecolab Inc., Baker Hughes Inc., Innospec Inc., JSC Gazprom Neftekhim Salavat, BASF SE, Evonik Industries AG, Clariant AG, GasHydrate LLC, and Schlumberger Limited.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics

The global hydrate inhibitors market report caters to various stakeholders in this industry including investors, suppliers, hydrate inhibitors manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the hydrate inhibitors market

Detailed Segmentation:

Global Hydrate Inhibitors Market, By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Global Hydrate Inhibitors Market, By Geography:

North America

U.S.

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Canada

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Europe

U.K.

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Germany

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

France

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Italy

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Spain

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Russia

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Rest of Europe

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Asia Pacific

China

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

India

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Japan

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

ASEAN

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Australia

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

South Korea

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Rest of Asia Pacific

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Latin America

Brazil

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Argentina

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Mexico

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Rest of Latin America

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Middle East

GCC

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Israel

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Rest of Middle East

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Africa

Northern Africa

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Central Africa

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

South Africa

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Company Profiles

Halliburton*

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Future Plans

Ashland Global Specialty Chemicals Inc.

Ecolab Inc.

Baker Hughes Inc.

Innospec Inc.

JSC Gazprom Neftekhim Salavat

BASF SE

Evonik Industries AG

Clariant AG

GasHydrate LLC

Schlumberger Limited

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Inhibitor Type
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Supply Side Drivers
    • Demand Side Drivers
    • Economic Drivers
    • Restraints
    • Market Opportunities
    • Regulatory Scenario
    • Industry Trend
    • Merger and Acquisitions
    • New Product Approvals/Launch
    • Promotion and Marketing Initiatives
  • Cost Tier Down Analysis

4. Global Hydrate Inhibitors Market, By Inhibitor Type, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Thermodynamic Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Low Dosage Hydrate Inhibitors (LDHI's)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Hybrid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Hydrate Inhibitors Market, By Region, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Share Analysis, By Country, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Country, 2017 - 2028
    • U.S.
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Canada
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
  • Europe
    • Market Share Analysis, By Country, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Country, 2017 - 2028
    • U.K.
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Germany
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • France
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Italy
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Spain
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Russia
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Rest of Europe
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
  • Asia Pacific
    • Market Share Analysis, By Country, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Country, 2017 - 2028
    • China
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • India
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Japan
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • ASEAN
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Australia
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • South Korea
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Rest of Asia Pacific
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
  • Latin America
    • Market Share Analysis, By Country, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Country, 2017 - 2028
    • Brazil
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Argentina
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Mexico
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Rest of Latin America
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
  • Middle East
    • Market Share Analysis, By Country, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Country, 2017 - 2028
    • GCC
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Israel
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Rest of Middle East
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
  • Africa
    • Market Share Analysis, By Country, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Country, 2017 - 2028
    • Northern Africa
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Central Africa
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • South Africa
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)

6. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • Halliburton
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Ashland Global Specialty Chemicals Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Ecolab Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Baker Hughes Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Innospec Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • JSC Gazprom Neftekhim Salavat
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • BASF SE
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Evonik Industries Ag
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Clariant AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • GasHydrate LLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Schlumberger Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
  • Analyst Views

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact
  • Browse 150 market data tables* and 90 figures* on "Hydrate Inhibitors Market" - Global forecast to 2028.